{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T05:40:42Z","timestamp":1790487642955,"version":"4.1.0"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100013279","name":"Joint Programming Initiative A healthy diet for a healthy life","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013279","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Talanta"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.talanta.2020.121074","type":"journal-article","created":{"date-parts":[[2020,4,27]],"date-time":"2020-04-27T06:56:47Z","timestamp":1587970607000},"page":"121074","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":68,"special_numbering":"C","title":["Stability of oxylipins during plasma generation and long-term storage"],"prefix":"10.1016","volume":"217","author":[{"given":"Elisabeth","family":"Koch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malwina","family":"Mainka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Dalle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annika I.","family":"Ostermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina M.","family":"Rund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Kutzner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura-Fabienne","family":"Froehlich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justine","family":"Bertrand-Michel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Gladine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nils Helge","family":"Schebb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.talanta.2020.121074_bib1","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.freeradbiomed.2019.05.012","article-title":"MS-based targeted metabolomics of eicosanoids and other oxylipins: analytical and inter-individual variabilities","volume":"144","author":"Gladine","year":"2019","journal-title":"Free Radic. Biol. Med."},{"issue":"5","key":"10.1016\/j.talanta.2020.121074_bib2","doi-asserted-by":"crossref","first-page":"513","DOI":"10.3945\/an.114.007732","article-title":"Advances in our understanding of oxylipins derived from dietary PUFAs","volume":"6","author":"Gabbs","year":"2015","journal-title":"Adv. Nutr."},{"issue":"7","key":"10.1016\/j.talanta.2020.121074_bib3","article-title":"An integrated omics analysis of eicosanoid biology (vol 50, pg 1015, 2009)","volume":"50","author":"Buczynski","year":"2009","journal-title":"J. Lipid Res."},{"issue":"5548","key":"10.1016\/j.talanta.2020.121074_bib4","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1126\/science.294.5548.1871","article-title":"Prostaglandins and leukotrienes: advances in eicosanoid biology","volume":"294","author":"Funk","year":"2001","journal-title":"Science"},{"issue":"7503","key":"10.1016\/j.talanta.2020.121074_bib5","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/nature13479","article-title":"Pro-resolving lipid mediators are leads for resolution physiology","volume":"510","author":"Serhan","year":"2014","journal-title":"Nature"},{"issue":"43","key":"10.1016\/j.talanta.2020.121074_bib6","doi-asserted-by":"crossref","first-page":"32720","DOI":"10.1074\/jbc.M110.118406","article-title":"Arachidonic acid-metabolizing cytochrome P450 enzymes are targets of omega-3 fatty acids","volume":"285","author":"Arnold","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.talanta.2020.121074_bib7","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1146\/annurev-pharmtox-011112-140244","article-title":"Impact of soluble epoxide hydrolase and epoxyeicosanoids on human health","volume":"53","author":"Morisseau","year":"2013","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"4","key":"10.1016\/j.talanta.2020.121074_bib8","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.bbalip.2014.10.007","article-title":"2nd, the isoprostanes--25 years later","volume":"1851","author":"Milne","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"issue":"10","key":"10.1016\/j.talanta.2020.121074_bib9","doi-asserted-by":"crossref","first-page":"5944","DOI":"10.1021\/cr200084z","article-title":"Free radical lipid peroxidation: mechanisms and analysis","volume":"111","author":"Yin","year":"2011","journal-title":"Chem. Rev."},{"issue":"2","key":"10.1016\/j.talanta.2020.121074_bib10","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.biocel.2009.09.015","article-title":"Prostaglandin E2 at new glance: novel insights in functional diversity offer therapeutic chances","volume":"42","author":"Legler","year":"2010","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"3","key":"10.1016\/j.talanta.2020.121074_bib11","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1124\/pr.56.3.3","article-title":"Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition","volume":"56","author":"Simmons","year":"2004","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.talanta.2020.121074_bib12","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.prostaglandins.2014.07.002","article-title":"omega-3 polyunsaturated fatty acids-derived lipid metabolites on angiogenesis, inflammation and cancer","volume":"113\u2013115","author":"Wang","year":"2014","journal-title":"Prostag. Other Lipid Mediat."},{"issue":"16","key":"10.1016\/j.talanta.2020.121074_bib13","doi-asserted-by":"crossref","first-page":"6530","DOI":"10.1073\/pnas.1304321110","article-title":"Epoxy metabolites of docosahexaenoic acid (DHA) inhibit angiogenesis, tumor growth, and metastasis","volume":"110","author":"Zhang","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"5","key":"10.1016\/j.talanta.2020.121074_bib14","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1165\/rcmb.2009-0155OC","article-title":"17,18-Epoxyeicosatetraenoic acid targets PPAR gamma and p38 mitogen-activated protein kinase to mediate its anti-inflammatory effects in the lung","volume":"43","author":"Morin","year":"2010","journal-title":"Am. J. Resp. Cell. Mol."},{"issue":"7","key":"10.1016\/j.talanta.2020.121074_bib15","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.bbalip.2017.04.001","article-title":"Mammalian ALOX15 orthologs exhibit pronounced dual positional specificity with docosahexaenoic acid","volume":"1862","author":"Kutzner","year":"2017","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.talanta.2020.121074_bib16","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.plefa.2016.10.005","article-title":"Effects of docosahexaenoic acid supplementation on PUFA levels in red blood cells and plasma","volume":"115","author":"Schuchardt","year":"2016","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"issue":"5","key":"10.1016\/j.talanta.2020.121074_bib17","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1093\/ajcn\/nqz016","article-title":"Plasma oxylipins respond in a linear dose-response manner with increased intake of EPA and DHA: results from a randomized controlled trial in healthy humans","volume":"109","author":"Ostermann","year":"2019","journal-title":"Am. J. Clin. Nutr."},{"issue":"7","key":"10.1016\/j.talanta.2020.121074_bib18","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1039\/C7FO00403F","article-title":"Effects of omega-3 fatty acid supplementation on the pattern of oxylipins: a short review about the modulation of hydroxy-, dihydroxy-, and epoxy-fatty acids","volume":"8","author":"Ostermann","year":"2017","journal-title":"Food Funct."},{"issue":"10","key":"10.1016\/j.talanta.2020.121074_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0076575","article-title":"Individual variation in lipidomic profiles of healthy subjects in response to omega-3 Fatty acids","volume":"8","author":"Nording","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.talanta.2020.121074_bib20","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2147\/JPR.S75160","article-title":"New insights into the use of currently available non-steroidal anti-inflammatory drugs","volume":"8","author":"Brune","year":"2015","journal-title":"J. Pain Res."},{"issue":"47","key":"10.1016\/j.talanta.2020.121074_bib21","doi-asserted-by":"crossref","first-page":"8973","DOI":"10.1021\/acs.jafc.6b04501","article-title":"Food polyphenol apigenin inhibits the cytochrome P450 monoxygenase branch of the arachidonic acid cascade","volume":"64","author":"Steuck","year":"2016","journal-title":"J. Agric. Food Chem."},{"issue":"10","key":"10.1016\/j.talanta.2020.121074_bib22","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1007\/s00216-014-8369-4","article-title":"Targeted metabolomics of the arachidonic acid cascade: current state and challenges of LC-MS analysis of oxylipins","volume":"407","author":"Willenberg","year":"2015","journal-title":"Anal. Bioanal. Chem."},{"issue":"4","key":"10.1016\/j.talanta.2020.121074_bib23","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.clinbiochem.2004.11.007","article-title":"Matrix effects: the Achilles heel of quantitative high-performance liquid chromatography-electrospray-tandem mass spectrometry","volume":"38","author":"Taylor","year":"2005","journal-title":"Clin. Biochem."},{"issue":"5","key":"10.1016\/j.talanta.2020.121074_bib24","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1021\/ac971078+","article-title":"Matrix effect in quantitative LC\/MS\/MS analyses of biological fluids: a method for determination of finasteride in human plasma at picogram per milliliter concentrations","volume":"70","author":"Matuszewski","year":"1998","journal-title":"Anal. Chem."},{"issue":"5\u20136","key":"10.1016\/j.talanta.2020.121074_bib25","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s10337-014-2768-8","article-title":"Development of an online-SPE-LC-MS\/MS method for 26 hydroxylated polyunsaturated fatty acids as rapid targeted metabolomics approach for the LOX, CYP, and autoxidation pathways of the arachidonic acid cascade","volume":"78","author":"Ostermann","year":"2015","journal-title":"Chromatographia"},{"issue":"2","key":"10.1016\/j.talanta.2020.121074_bib26","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1089\/bio.2015.0005","article-title":"Preanalytical investigation of polyunsaturated fatty acids and eicosanoids in human plasma by liquid chromatography-tandem mass spectrometry","volume":"14","author":"Dorow","year":"2016","journal-title":"Biopreserv. Biobanking"},{"issue":"12","key":"10.1016\/j.talanta.2020.121074_bib27","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/j.bbalip.2018.10.003","article-title":"Effects of anticoagulants and storage conditions on clinical oxylipid levels in human plasma","volume":"1863","author":"Jonasdottir","year":"2018","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.talanta.2020.121074_bib28","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.prostaglandins.2014.05.002","article-title":"Comparison of the effects of long-chain omega-3 fatty acid supplementation on plasma levels of free and esterified oxylipins","volume":"113","author":"Schebb","year":"2014","journal-title":"Prostag. Other Lipid Mediat."},{"issue":"22","key":"10.1016\/j.talanta.2020.121074_bib29","doi-asserted-by":"crossref","first-page":"10721","DOI":"10.1073\/pnas.89.22.10721","article-title":"2nd, Non-cyclooxygenase-derived prostanoids (F2-isoprostanes) are formed in situ on phospholipids","volume":"89","author":"Morrow","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.talanta.2020.121074_bib30","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.prostaglandins.2019.02.006","article-title":"A strategy for validating concentrations of oxylipin standards for external calibration","volume":"141","author":"Hartung","year":"2019","journal-title":"Prostag. Other Lipid Mediat."},{"key":"10.1016\/j.talanta.2020.121074_bib31","series-title":"Guideline on Bioanalytical Method Validation","author":"Agency","year":"2011"},{"key":"10.1016\/j.talanta.2020.121074_bib32","series-title":"Targeting Esterified Oxylipin by LC-MS - Effect of Sample Preparation on Oxylipin Pattern","author":"Ostermann","year":"2019"},{"key":"10.1016\/j.talanta.2020.121074_bib33","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.aca.2017.11.002","article-title":"Development of an LC-ESI(-)-MS\/MS method for the simultaneous quantification of 35 isoprostanes and isofurans derived from the major n3- and n6-PUFAs","volume":"1037","author":"Rund","year":"2018","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.talanta.2020.121074_bib34","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3389\/fphar.2019.00169","article-title":"Development of an optimized LC-MS method for the detection of specialized pro-resolving mediators in biological samples","volume":"10","author":"Kutzner","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"40","key":"10.1016\/j.talanta.2020.121074_bib35","doi-asserted-by":"crossref","first-page":"4935","DOI":"10.1039\/C8AY01753K","article-title":"Intra-individual variance of the human plasma oxylipin pattern: low inter-day variability in fasting blood samples versus high variability during the day","volume":"10","author":"Ostermann","year":"2018","journal-title":"Anal. Meth. UK"},{"issue":"6","key":"10.1016\/j.talanta.2020.121074_bib36","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s11883-009-0061-3","article-title":"Impact of circulating esterified eicosanoids and other oxylipins on endothelial function","volume":"11","author":"Shearer","year":"2009","journal-title":"Curr. Atherosclerosis Rep."},{"issue":"8","key":"10.1016\/j.talanta.2020.121074_bib37","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/S0022-2275(20)32202-1","article-title":"A method for the determination of 5,6-EET using the lactone as an intermediate in the formation of the diol","volume":"39","author":"Fulton","year":"1998","journal-title":"J. Lipid Res."},{"issue":"4","key":"10.1016\/j.talanta.2020.121074_bib38","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0748-5514(85)90129-1","article-title":"Peroxidation of linolenic acid promoted by human polymorphonuclear leucocytes","volume":"1","author":"Carlin","year":"1985","journal-title":"J. Free Radic. Biol. Med."},{"issue":"19","key":"10.1016\/j.talanta.2020.121074_bib39","doi-asserted-by":"crossref","first-page":"8085","DOI":"10.1021\/ac901282n","article-title":"Quantitative profiling method for oxylipin metabolome by liquid chromatography electrospray ionization tandem mass spectrometry","volume":"81","author":"Yang","year":"2009","journal-title":"Anal. Chem."},{"issue":"21","key":"10.1016\/j.talanta.2020.121074_bib40","doi-asserted-by":"crossref","first-page":"6447","DOI":"10.1021\/ja00411a032","article-title":"Unified mechanism for poly-unsaturated fatty-acid autoxidation - competition of peroxy radical hydrogen-atom abstraction, beta-scission, and cyclization","volume":"103","author":"Porter","year":"1981","journal-title":"J. Am. Chem. Soc."},{"issue":"41","key":"10.1016\/j.talanta.2020.121074_bib41","doi-asserted-by":"crossref","first-page":"29890","DOI":"10.1074\/jbc.M703108200","article-title":"Identification of novel autoxidation products of the omega-3 fatty acid eicosapentaenoic acid in vitro and in vivo","volume":"282","author":"Yin","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"Pt 1","key":"10.1016\/j.talanta.2020.121074_bib42","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1042\/bj3060247","article-title":"Effect of inhibitor time-dependency on selectivity towards cyclooxygenase isoforms","volume":"306","author":"Ouellet","year":"1995","journal-title":"Biochem. J."},{"issue":"16","key":"10.1016\/j.talanta.2020.121074_bib43","doi-asserted-by":"crossref","first-page":"3825","DOI":"10.1021\/jm070270t","article-title":"Orally bioavailable potent soluble epoxide hydrolase inhibitors","volume":"50","author":"Hwang","year":"2007","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.talanta.2020.121074_bib44","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.gene.2013.05.008","article-title":"Soluble epoxide hydrolase: gene structure, expression and deletion","volume":"526","author":"Harris","year":"2013","journal-title":"Gene"},{"issue":"22","key":"10.1016\/j.talanta.2020.121074_bib45","doi-asserted-by":"crossref","first-page":"10282","DOI":"10.1016\/S0021-9258(18)67521-0","article-title":"The involvement of iron in lipid peroxidation. Importance of ferric to ferrous ratios in initiation","volume":"261","author":"Braughler","year":"1986","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.talanta.2020.121074_bib46","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.bbalip.2014.11.012","article-title":"Targeted lipidomic strategies for oxygenated metabolites of polyunsaturated fatty acids","volume":"1851","author":"Astarita","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"issue":"10","key":"10.1016\/j.talanta.2020.121074_bib47","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1016\/j.bbalip.2019.05.002","article-title":"Impact of food polyphenols on oxylipin biosynthesis in human neutrophils","volume":"1864","author":"Hartung","year":"2019","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"issue":"10","key":"10.1016\/j.talanta.2020.121074_bib48","doi-asserted-by":"crossref","first-page":"5866","DOI":"10.1021\/cr200246d","article-title":"Lipoxygenase and leukotriene pathways: biochemistry, biology, and roles in disease","volume":"111","author":"Haeggstrom","year":"2011","journal-title":"Chem. Rev."},{"issue":"5","key":"10.1016\/j.talanta.2020.121074_bib49","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/BF02259611","article-title":"Human whole blood assays for inhibition of prostaglandin G\/H synthases-1 and -2 using A23187 and lipopolysaccharide stimulation of thromboxane B2 production","volume":"45","author":"Young","year":"1996","journal-title":"Inflamm. Res."},{"issue":"2","key":"10.1016\/j.talanta.2020.121074_bib50","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3390\/metabo2020337","article-title":"Targeted chiral analysis of bioactive arachidonic Acid metabolites using liquid-chromatography-mass spectrometry","volume":"2","author":"Mesaros","year":"2012","journal-title":"Metabolites"},{"issue":"2","key":"10.1016\/j.talanta.2020.121074_bib51","first-page":"314","article-title":"Effect of different omega-6\/omega-3 polyunsaturated fatty acid ratios on the formation of monohydroxylated fatty acids in THP-1 derived macrophages","volume":"4","author":"Keeren","year":"2015","journal-title":"Biology (Basel)"},{"issue":"2","key":"10.1016\/j.talanta.2020.121074_bib52","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/BF02265118","article-title":"A human whole blood assay for clinical evaluation of biochemical efficacy of cyclooxygenase inhibitors","volume":"45","author":"Brideau","year":"1996","journal-title":"Inflamm. Res."},{"issue":"5","key":"10.1016\/j.talanta.2020.121074_bib53","doi-asserted-by":"crossref","first-page":"694","DOI":"10.3324\/haematol.10999","article-title":"Platelet aggregation studies: autologous platelet-poor plasma inhibits platelet aggregation when added to platelet-rich plasma to normalize platelet count","volume":"92","author":"Cattaneo","year":"2007","journal-title":"Haematologica"},{"issue":"12","key":"10.1016\/j.talanta.2020.121074_bib54","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1515\/cclm-2016-0079","article-title":"The effect of centrifugation speed and time on pre-analytical platelet activation","volume":"54","author":"Soderstrom","year":"2016","journal-title":"Clin. Chem. Lab. Med."},{"issue":"2","key":"10.1016\/j.talanta.2020.121074_bib55","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1373\/clinchem.2013.211979","article-title":"Quality markers addressing preanalytical variations of blood and plasma processing identified by broad and targeted metabolite profiling","volume":"60","author":"Kamlage","year":"2014","journal-title":"Clin. Chem."},{"issue":"7","key":"10.1016\/j.talanta.2020.121074_bib56","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1161\/CIRCRESAHA.114.301597","article-title":"Platelet lipidomics: modern day perspective on lipid discovery and characterization in platelets","volume":"114","author":"O'Donnell","year":"2014","journal-title":"Circ. Res."},{"issue":"6","key":"10.1016\/j.talanta.2020.121074_bib57","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1515\/CCLM.2008.170","article-title":"Haemolysis: an overview of the leading cause of unsuitable specimens in clinical laboratories","volume":"46","author":"Lippi","year":"2008","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.talanta.2020.121074_bib58","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.plefa.2019.09.001","article-title":"Temperature and time-dependent effects of delayed blood processing on oxylipin concentrations in human plasma","volume":"150","author":"Ramsden","year":"2019","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"issue":"5","key":"10.1016\/j.talanta.2020.121074_bib59","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1007\/s00216-014-8377-4","article-title":"Comparison of sample preparation methods for the quantitative analysis of eicosanoids and other oxylipins in plasma by means of LC-MS\/MS","volume":"407","author":"Ostermann","year":"2015","journal-title":"Anal. Bioanal. Chem."},{"issue":"3","key":"10.1016\/j.talanta.2020.121074_bib60","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1172\/JCI3985","article-title":"The relationship of hydroxyeicosatetraenoic acids and F-2-isoprostanes to plaque instability in human carotid atherosclerosis","volume":"103","author":"Mallat","year":"1999","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.talanta.2020.121074_bib61","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1006\/abio.1993.1091","article-title":"Quantitation of hydroperoxy-eicosatetraenoic acids and hydroxy-eicosatetraenoic acids as indicators of lipid-peroxidation using gas-chromatography mass-spectrometry","volume":"209","author":"Guido","year":"1993","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.talanta.2020.121074_bib62","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ab.2013.12.030","article-title":"Minimizing artifactual elevation of lipid peroxidation products (F-2-isoprostanes) in plasma during collection and storage","volume":"449","author":"Barden","year":"2014","journal-title":"Anal. Biochem."}],"container-title":["Talanta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039914020303659?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039914020303659?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T12:44:53Z","timestamp":1758545093000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039914020303659"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":62,"alternative-id":["S0039914020303659"],"URL":"https:\/\/doi.org\/10.1016\/j.talanta.2020.121074","relation":{},"ISSN":["0039-9140"],"issn-type":[{"value":"0039-9140","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stability of oxylipins during plasma generation and long-term storage","name":"articletitle","label":"Article Title"},{"value":"Talanta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.talanta.2020.121074","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"121074"}}